Home
>
US Stocks
>
Abeona Therapeutics Inc
Abeona Therapeutics Inc
ABEO

Abeona Therapeutics Inc (ABEO)

$0.851.16%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$0.86
Today Low/High
$0.84 / $0.86
52 Week Low/High
$0.84 / $3.79
Market Cap
$87.06M

Company Details

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing gene and cell therapies for serious diseases. Abeona's clinical programs include EB-101, its autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa in Phase 3 development, as well as ABO-102 and ABO-101, novel AAV-based gene therapies for Sanfilippo syndrome types A and B (MPS IIIA and MPS IIIB), respectively, in Phase 1/2 development. The Company's portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical needs. Abeona's novel, next-generation AIM™ capsids have shown potential to improve tropism profiles for a variety of devastating diseases. Abeona's fully functional, gene and cell therapy GMP manufacturing facility produces EB-101 for the pivotal Phase 3 VIITAL™ study and is capable of clinical and commercial production of AAV-based gene therapies.
Organisation
Abeona Therapeutics Inc
Headquaters
New York, New York, US
Employees
76
Industry
Health Technology
CEO
Joao Siffert

Discover more

Frequently Asked Questions

What is Abeona Therapeutics Inc (ABEO) share price today?

Can Indians buy Abeona Therapeutics Inc (ABEO) shares?

How can I buy Abeona Therapeutics Inc (ABEO) shares from India?

Can Fractional shares of Abeona Therapeutics Inc (ABEO) be purchased?

What are the documents required to start investing in Abeona Therapeutics Inc (ABEO) stocks?

We are a SEBI registered investement advisor